KERZBERG E

Last name: KERZBERG E

2022 (v1)

Publication

Metadata-only

Late Skin Fibrosis in Systemic Sclerosis: A Study from the EUSTAR Cohort.

Hughes M Huang S Alegre-Sancho JJ

No description

Uploaded on: February 14, 2024
2022 (v1)

Publication

Metadata-only

Digital pitting scars are associated with a severe disease course and death in systemic sclerosis: a study from the EUSTAR cohort.

Hughes M Heal C Henes J

No description

Uploaded on: February 14, 2024
2012 (v1)

Publication

Metadata-only

Patient's global assessment of disease activity and patient's assessment of general health for rheumatoid arthritis activity assessment: are they equivalent?

Khan NA Spencer HJ Abda EA

Patient's global assessment of disease activity and patient's assessment of general health ratings differ in their determinants. Although they are individually not equivalent, they may be used interchangeably for calculating composite indices for RA activity assessment.

Uploaded on: May 13, 2023
2019 (v1)

Publication

Metadata-only

Progressive skin fibrosis is associated with a decline in lung function and worse survival in patients with diffuse cutaneous systemic sclerosis in the European Scleroderma Trials and Research (EUSTAR) cohort.

Wu W Jordan S Graf N

No description

Uploaded on: April 14, 2023
2019 (v1)

Publication

Metadata-only

Predictors of disease worsening defined by progression of organ damage in diffuse systemic sclerosis: a European Scleroderma Trials and Research (EUSTAR) analysis.

Becker M Graf N Sauter R

Objectives Mortality and worsening of organ function are desirable endpoints for clinical trials in systemic sclerosis (SSc). The aim of this study was to identify factors that allow enrichment of patients with these endpoints, in a population of patients from the European Scleroderma Trials and Research group database. Methods Inclusion...

Uploaded on: April 14, 2023

KERZBERG E

Recent uploads